Creathor

www.creathor.com

VCMatch tracks Creathor as an investor focused on AI/ML, Enterprise SaaS, and Digital Health companies, Series A and Series B rounds, Europe, Germany, and Switzerland markets, and $4m to $8m check sizes. Upload your deck to compare your startup against the full private matching profile.

Check Size

$4m to $8m

Stages

Series A, Series B

Focus Areas

AI/ML, Enterprise SaaS, Digital Health

Geography

Europe, Germany, and Switzerland

Investment Thesis

Creathor Ventures positions itself as a long‑term, sector‑specialist investor that backs companies “at the frontier of technology and science” with hands‑on support to help founders reach exits. The firm emphasizes investing across both technology and life sciences (and their intersection such as digital health), acting as lead investor on rounds and partnering closely with founders to navigate product, regulatory and go‑to‑market challenges.

Is Creathor right for your startup?

Upload your pitch deck to compare your startup against VCMatch's private investor profile, including fit, timing, and next-step signals.

See If You're a Match View Sample Match

Investment Focus

Who should take a closer look

Creathor is most relevant for founders raising Series A and Series B rounds in AI/ML, Enterprise SaaS, Digital Health, and Biotech, especially across Europe, Germany, and Switzerland, with public check-size signals around $4m to $8m.

Focus statement

Stated focus: tech and healthcare / life sciences, including the growing intersection of the two (e.g., digital health). The site says: "For more than seven fund generations, our focus has been on tech and life sciences now as well as on the constantly increasing intersection of these two areas (e.g., digital health)."

Value Add

Long track record: "We have been investing at the frontier of technology and science for over 30 years." (including predecessor funds).
Cross‑domain expertise: ability to invest in both deep tech and life sciences — "There are not many VCs in Europe who can do both."
Proven outcomes: cites "220" tech companies funded and "7 Billion $ exits" (figures shown on the site).
Operational and scientific senior team: founders/partners include experienced industry operators and scientists (e.g., founder with PhD in mathematics and partners with industry roles at Roche, Boehringer Mannheim, 3i), supporting domain credibility in healthcare and tech.
Active, leading role in rounds: examples on the site show Creathor acting as lead investor (e.g., Blueprint Genetics, Wunderflats Series B) and providing follow‑on/operational support.
Europe focus and portfolio evidence across geographies (Germany, Finland, Switzerland) with B2B and consumer plays across proptech, AI/genomics, industrial comms, HR platforms and pharma.